Organon (OGN) EBT Margin (2020 - 2026)
Organon (OGN) recorded quarterly EBT Margin of 14.59% in Q1 2026, up 248.55% quarter-over-quarter from 9.82% in Q4 2025, and up 791.0% on a YoY basis from 1.64% in Q1 2025.
Organon (OGN) EBT Margin (2020 - 2026) Analysis & Trends
Organon's EBT Margin history runs 7 years deep, the most recent figure standing at 14.59% for Q1 2026.
- In Q1 2026, EBT Margin rose 791.0% year-over-year to 14.59%; the TTM figure through Mar 2026 stood at 8.71% (down 196.0% YoY), while the FY2025 annual figure was 6.84%, down 577.0% from the prior year.
- EBT Margin was 14.59% for Q1 2026 at Organon, up from 9.82% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 37.85% in Q4 2022 to a low of 9.82% in Q4 2025.
- Historically, EBT Margin has averaged 13.92% across 5 years, with a median of 14.59% in 2026.
- The sharpest annual moves came in 2022 and 2023: EBT Margin jumped 2312 bps in 2022, then tumbled 3134 bps in 2023.
- A 5-year view of EBT Margin shows it stood at 37.85% in 2022, then tumbled by 83 bps to 6.51% in 2023, then grew by 25 bps to 8.1% in 2024, then plunged by 221 bps to 9.82% in 2025, then jumped by 249 bps to 14.59% in 2026.
- The last three EBT Margin figures came in at 14.59% (Q1 2026), 9.82% (Q4 2025), and 15.17% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,026,132.38 Bn | 93,026,127.42 Bn | 7.76 Bn | 28.10% |
| 2 | Eli Lilly | 1,022.62 Bn | 1,017.34 Bn | 16.22 Bn | 44.70% |
| 3 | Johnson & Johnson | 570.65 Bn | 548.59 Bn | 15.96 Bn | 24.89% |
| 4 | AbbVie | 398.73 Bn | 389.38 Bn | 10.78 Bn | 6.93% |
| 5 | Merck | 295.53 Bn | 289.88 Bn | 12.09 Bn | -21.49% |
| 6 | Amgen | 186.30 Bn | 174.26 Bn | 5.87 Bn | 24.18% |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn | 37.07% |
| 8 | Pfizer | 146.09 Bn | 133.32 Bn | -1.21 Bn | 135.53% |
| 9 | Bristol Myers Squibb | 114.98 Bn | 104.53 Bn | 8.07 Bn | 28.20% |
| 10 | Organon | 3.49 Bn | 2.37 Bn | 783.00 Mn | 14.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.59% |
| Dec 31, 2025 | -9.82% |
| Sep 30, 2025 | 15.17% |
| Jun 30, 2025 | 14.37% |
| Mar 31, 2025 | 6.68% |
| Dec 31, 2024 | 8.10% |
| Sep 30, 2024 | 13.08% |
| Jun 30, 2024 | 14.62% |
| Mar 31, 2024 | 14.55% |
| Dec 31, 2023 | 6.51% |
| Sep 30, 2023 | 5.27% |
| Jun 30, 2023 | 15.80% |
| Mar 31, 2023 | 15.28% |
| Dec 31, 2022 | 37.85% |
| Sep 30, 2022 | 18.35% |
| Jun 30, 2022 | 18.11% |
| Mar 31, 2022 | 28.21% |
| Dec 31, 2021 | 14.72% |
| Sep 30, 2021 | 24.31% |
| Jun 30, 2021 | 27.40% |